SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-024779
Filing Date
2024-05-22
Accepted
2024-05-22 17:43:36
Documents
3
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1716414206.html 3  
1 FORM 3 wk-form3_1716414206.xml 3 2265
2 EX-24 poa_pjosephsv1.htm EX-24 6186
3 poa_pjosephsv1001.jpg GRAPHIC 165180
  Complete submission text file 0001628280-24-024779.txt   237503
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD. CHASKA MN 55318
Business Address
Josephs Paul (Reporting) CIK: 0002022547 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 24974579